Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Subject
Sign on to:
My Account
Receive email
updates
Edit Profile
CMU Intellectual Repository
Browsing by Author Sumitra Thongprasert
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 7 to 26 of 34
< previous
next >
Issue Date
Title
Author(s)
15-Jul-2015
Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy
Tony Mok
;
Yi Long Wu
;
Jin Soo Lee
;
Chong Jen Yu
;
Virote Sriuranpong
;
Jennifer Sandoval-Tan
;
Guia Ladrera
;
Sumitra Thongprasert
;
Vichien Srimuninnimit
;
Meilin Liao
;
Yunzhong Zhu
;
Caicun Zhou
;
Fatima Fuerte
;
Benjamin Margono
;
Wei Wen
;
Julie Tsai
;
Matt Truman
;
Barbara Klughammer
;
David S. Shames
;
Lin Wu
24-Sep-2009
Editorial: Update on Anti-EGFR therapy
Daniel Chua
;
Peter Fasching
;
Brigette Ma
;
Sumitra Thongprasert
;
Lori Wirth
1-Feb-2017
Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC
Yi Long Wu
;
Nagahiro Saijo
;
Sumitra Thongprasert
;
J. C.H. Yang
;
Baohui Han
;
Benjamin Margono
;
Busayamas Chewaskulyong
;
Patrapim Sunpaweravong
;
Yuichiro Ohe
;
Yukito Ichinose
;
Jin Ji Yang
;
Tony S.K. Mok
;
Helen Young
;
Vincent Haddad
;
Yuri Rukazenkov
;
Masahiro Fukuoka
1-Jan-2017
Efficacy and safety of first-line necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin in East Asian patients with stage IV squamous non-small cell lung cancer: A subgroup analysis of the phase 3, open-label, randomized SQUIRE study
Keunchil Park
;
Eun Kyung Cho
;
Maximino Bello
;
Myung Ju Ahn
;
Sumitra Thongprasert
;
Eun Kee Song
;
Victoria Soldatenkova
;
Henrik Depenbrock
;
Tarun Puri
;
Mauro Orlando
1-Jun-2011
Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial
Tony S K Mok
;
Te Chun Hsia
;
Chun Ming Tsai
;
Kenneth Tsang
;
Gee Chen Chang
;
John Wen Cheng Chang
;
Sirisinha Thitiya
;
Virote Sriuranpong
;
Sumitra Thongprasert
;
Daniel Tt Chua
;
Nicola Moore
;
Christian Manegold
1-Jan-2014
Epidermal growth factor receptor mutation testing in Thailand: A cost-utility analysis
Unchalee Permsuwan
;
Narawadee Niamhun
;
Narumon Tanatip
;
Sumitra Thongprasert
14-Jul-2005
Erlotinib in previously treated non-small-cell lung cancer
Frances A. Shepherd
;
José Rodrigues Pereira
;
Tudor Ciuleanu
;
Huat Tan Eng
;
Vera Hirsh
;
Sumitra Thongprasert
;
Daniel Campos
;
Savitree Maoleekoonpiroj
;
Michael Smylie
;
Renato Martins
;
M. Van Kooten
;
Mircea Dediu
;
Brian Findlay
;
Dongsheng Tu
;
Dianne Johnston
;
Andrea Bezjak
;
Gary Clark
;
Pedro Santabárbara
;
Lesley Seymour
28-May-2007
Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma
Chalyut Charoentum
;
Sumitra Thongprasert
;
Busyamas Chewaskulyong
;
Sutthirak Munprakan
3-Sep-2009
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
Tony S. Mok
;
Yi Long Wu
;
Sumitra Thongprasert
;
Chih Hsin Yang
;
Da Tong Chu
;
Nagahiro Saijo
;
Patrapim Sunpaweravong
;
Baohui Han
;
Benjamin Margono
;
Yukito Ichinose
;
Yutaka Nishiwaki
;
Yuichiro Ohe
;
Jin Ji Yang
;
Busyamas Chewaskulyong
;
Haiyi Jiang
;
Emma L. Duffield
;
Claire L. Watkins
;
Alison A. Armour
;
Masahiro Fukuoka
1-Jun-2017
Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival
Chee Khoon Lee
;
Lucy Davies
;
Yi Long Wu
;
Tetsuya Mitsudomi
;
Akira Inoue
;
Rafael Rosell
;
Caicun Zhou
;
Kazuhiko Nakagawa
;
Sumitra Thongprasert
;
Masahiro Fukuoka
;
Sally Lord
;
Ian Marschner
;
Yu Kang Tu
;
Richard J. Gralla
;
Val Gebski
;
Tony Mok
;
James Chih Hsin Yang
1-Jan-2011
Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS)
Sumitra Thongprasert
;
Emma Duffield
;
Nagahiro Saijo
;
Yi Long Wu
;
James Chih Hsin Yang
;
Da Tong Chu
;
Meilin Liao
;
Yuh Min Chen
;
Han Pin Kuo
;
Shunichi Negoro
;
Kwok Chi Lam
;
Alison Armour
;
Patrick Magill
;
Masahiro Fukuoka
1-May-2013
Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: A meta-analysis
Chee Khoon Lee
;
Chris Brown
;
Richard J. Gralla
;
Vera Hirsh
;
Sumitra Thongprasert
;
Chun Ming Tsai
;
Eng Huat Tan
;
James Chung Man Ho
;
Da Tong Chu
;
Adel Zaatar
;
Jemela Anne Osorio Sanchez
;
Vu Van Vu
;
Joseph Siu Kie Au
;
Akira Inoue
;
Siow Ming Lee
;
Val Gebski
;
James Chih Hsin Yang
1-Jun-2011
An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia
John Wen Cheng Chang
;
Sumitra Thongprasert
;
Elaine Wright
;
Kenneth Tsang
;
Heung Tae Kim
;
Myung Ju Ahn
;
Joo Hang Kim
;
Jin Hyoung Kang
;
Sang We Kim
;
Stefan Walzer
1-Sep-2005
Lung cancer in Maharaj Nakorn Chiang Mai Hospital: Comparison of the clinical manifestations between the young and old age groups
Athavudh Deesomchok
;
Namporn Dechayonbancha
;
Sumitra Thongprasert
1-Sep-2010
Lung cancer working group report
Nagahiro Saijo
;
Masahiro Fukuoka
;
Sumitra Thongprasert
;
Yukito Ichinose
;
Tetsuya Mitsudomi
;
Tony Shu Kam Mok
;
Yuichiro Ohe
;
Keunchil Park
;
Yi Long Wu
1-Oct-2007
Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
Chaiyut Charoentum
;
Sumitra Thongprasert
;
Busayamas Chewasakulyong
1-Nov-2007
Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
Chaiyut Charoentum
;
Sumitra Thongprasert
;
Busayamas Chewasakulyong
;
Juntima Euathrongchit
;
Sirikul Sorraritchingchai
;
Sutthirak Munprakan
1-Feb-2006
A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer
Sumitra Thongprasert
;
Sirikul Soorraritchingchai
;
Busayamas Chewaskulyong
;
Chaiyut Charoentum
;
Sutthirak Munprakan
1-Jan-2012
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
Jun Ho Yi
;
Sumitra Thongprasert
;
Jeeyun Lee
;
D. C. Doval
;
Se Hoon Park
;
Joon Oh Park
;
Young Suk Park
;
Won Ki Kang
;
Ho Yeong Lim
27-May-2014
Prevalence and relationship between major depressive disorder and lung cancer: A cross-sectional study
Benchalak Maneeton
;
Narong Maneeton
;
Jirayu Reungyos
;
Suthi Intaprasert
;
Samornsri Leelarphat
;
Sumitra Thongprasert